How many employees work at HEFAME?

Hermandad Farmaceutica del Mediterraneo SCRL has approximately 691 total employees worldwide as of March 2026, according to Revelio Labs workforce intelligence data. HEFAME’s total headcount has grown 3.7% from 667 employees in 2023 to 691 in 2026.

Data source: Revelio LabsCoverage: Global workforce, 20232026Published August 2026

Is HEFAME hiring right now?

Yes, HEFAME is actively hiring. HEFAME had 12 active job postings in 2026, a 120.0% increase from 2025 see job openings & hiring trends.

About HEFAME’s Workforce

Hermandad Farmaceutica del Mediterraneo SCRL is a Pharmaceuticals company that employs 691 people worldwide as of March 2026. It is the 9th-largest by headcount among its peers. Founded in 1950, the company is headquartered in Spain.

HEFAME's workforce has grown 3.7% from 2023 to 2026, though it is down 0.6% year over year in 2026. It fell to a low of 645 in 2024 Q1 before recovering. Its workforce is concentrated most in Southern Europe (98.1%), followed by South America (0.9%) and Sub-Saharan Africa (0.6%).

HEFAME's functional groups are Sales and Marketing (35.1%), Engineering (32.9%), and Finance and Operations (32.1%), with Engineering growing fastest (up 2.7%). The average salary is $29,554, ranging from a median of $22,000 in Southern Europe to $10,000 in South America, up 2.5% year over year in 2026.

HEFAME's active job postings rose 120.0% in 2026 to 12, with new postings per month climbing from 4 in 2023 to 7 in 2026. Overall employee sentiment is negative and declining.

Sourced from Revelio Labs workforce data.

Headquarters
Spain
Founded
1950
Industry
Pharmaceuticals
Employees
691
YoY
-0.6% (+11)

Unlock hiring rate, attrition rate, and 12 additional workforce metrics for HEFAME. Compare to peers, export the dataset, and access the full quarterly history.

Unlock Metrics

HEFAME Annual Employee Count (2023-2026)

Interactive chart of HEFAME annual worldwide employee count from 2023 to 2026.
  • HEFAME had 691 employees in 2026, a 0.6% decline (+11) from 2025.
  • HEFAME had 693 employees in 2025, a 1.4% increase (+25) from 2024.
  • HEFAME had 668 employees in 2024, a 0.9% decline (+22) from 2023.
  • HEFAME had 646 employees in 2023, a 3.1% decline (-7) from 2022.

HEFAME's total workforce has grown from 667 employees in 2023 to 691 in 2026.

Hermandad Farmaceutica del Mediterraneo SCRL quarterly employee count

YearQtrEmployeesYoY ChangeYoY %
2026Q1691+11-0.6%
2025Q4693+25+1.4%
2025Q3687+30+1.2%
2025Q2700+24+1.5%
2025Q1680+35+1.0%
2024Q4668+22-0.9%
2024Q3657+5-1.0%
2024Q2676+9-0.4%
2024Q1645-1-1.6%
2023Q4646-7-3.1%
2023Q3652+14-2.1%
2023Q2667+5-3.1%

See HEFAME's complete headcount history, including quarterly breakdowns.

Get the Data

HEFAME Employee Count by Region (2026)

Southern Europe accounts for the largest share of HEFAME's global workforce with approximately 98% of total employees, followed by South America and Sub-Saharan Africa.

HEFAME employees by region

RegionEmployees% of Total
Southern Europe67698.1%
South America60.9%
Sub-Saharan Africa40.6%
South Asia10.2%
North America10.1%
Western Europe00.0%

Drill into city-level data, hiring trends by region, and historic geographic shifts.

Unlock Geographic Data

HEFAME Employee Count by Department (2026)

HEFAME's employee groups are Sales and Marketing (35.1%), Engineering (32.9%), and Finance and Operations (32.1%).

HEFAME employees by department

DepartmentEmployees% of Total
Sales and Marketing24035.1%
Engineering22532.9%
Finance and Operations22032.1%

Compare HEFAME's department mix to industry peers.

See Full Data

HEFAME Employee Salary by Region (2026)

HEFAME's average employee salary is $29,554 globally. Employees in Southern Europe receive the highest compensation. Pay is lowest in South America, at a median of $10,000.

HEFAME median employee salary by region (USD)

RegionMedian Salary
Southern Europe$22,000
South America$10,000

Unlock salary by role, level, and city — and compare to HEFAME's industry peers.

Unlock Salary Data

HEFAME Job Openings and Hiring Trends (2023-2026)

Interactive chart of HEFAME annual active job postings from 2023 to 2026.
  • HEFAME had 12 active job postings in 2026, a 120.0% increase (+4) from 2025.
  • HEFAME had 8 active job postings in 2025, a 11.8% decline (-1) from 2024.
  • HEFAME had 9 active job postings in 2024, a 25.0% increase (+2) from 2023.
  • HEFAME had 7 active job postings in 2023, a 54.5% increase from 2022.
  • Hiring velocity in 2026: 7 new roles/month, up from 6 in 2025 and 4 in 2024.

HEFAME's hiring is accelerating: active job postings rose 120.0% in 2026 to 12, with new postings per month climbing from 4 in 2023 to 7 in 2026.

Track new postings per month, role-level demand, and hiring velocity vs. peers.

Unlock Hiring Data

HEFAME Employee Sentiment (2026)

Revelio Labs tracks employee sentiment across HEFAME's workforce based on public professional data. Overall sentiment is negative and has declined year over year in 2026.

Overall

NegativePositive

Unlock the full sentiment breakdown by department, tenure, and trend over time.

Unlock Sentiment

Similar Companies

Frequently Asked Questions About HEFAME

How fast is HEFAME growing?
In 2026, HEFAME's headcount shrank 0.6% to 691 employees, up from 680 in 2025.
See the full headcount history
Where are HEFAME employees located?
Most HEFAME employees are based in Southern Europe (98.1% of headcount), followed by South America and Sub-Saharan Africa.
Explore where the workforce is based
What is the average salary at HEFAME?
The average employee salary at HEFAME is approximately $29.6k per year.
Analyze the salary distribution
How many new job postings does HEFAME open per year?
In Q1 2026, HEFAME opened 21 new job postings. In 2025, HEFAME opened 71 new job postings — about 6 per month.
Track hiring trends by role
When was HEFAME founded and where is it headquartered?
HEFAME was founded in 1950 and is headquartered in Spain.
Compare HEFAME to industry peers

Speak with a workforce expert about HEFAME.

Book a Demo

See something that doesn't look right? Reach out and our team will review it.